Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib

OBJECTIVE: To characterise changes in selected haematological parameters following once-daily oral baricitinib dosing. METHODS: Data were pooled from eight randomised clinical trials (four phase 3, three phase 2, one phase 1b) and one long-term extension. Changes in haematological parameters were ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Kay, Jonathan, Harigai, Masayoshi, Rancourt, Josh, Dickson, Christina, Melby, Thomas, Issa, Maher, de la Torre, Inmaculada, Isaka, Yoshitaka, Cardoso, Anabela, Saifan, Chadi, Keystone, Edward C, van Vollenhoven, Ronald F, Giles, Jon T, Huizinga, Tom WJ, Kremer, Joel M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722368/
https://www.ncbi.nlm.nih.gov/pubmed/33028675
http://dx.doi.org/10.1136/rmdopen-2020-001370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722368/
https://www.ncbi.nlm.nih.gov/pubmed/33028675
http://dx.doi.org/10.1136/rmdopen-2020-001370

Ejemplares similares